Skip to main content

and
  1. Article

    Open Access

    Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis

    The acetylcholinesterase inhibitors (AChEIs) donepezil, galantamine, and rivastigmine are commonly used in the management of various forms of dementia.

    Nadine Bittner, Cleo S. M. Funk, Alexander Schmidt, Felix Bermpohl in Drugs & Aging (2023)

  2. No Access

    Article

    Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study

    Given the polygenic nature of antipsychotic-induced weight gain (AIWG), we investigated whether polygenic risk scores (PRS) for various psychiatric and metabolic traits were associated with AIWG. We included i...

    Kazunari Yoshida, Victoria S. Marshe, Samar S. M. Elsheikh in The Pharmacogenomics Journal (2023)

  3. Article

    Open Access

    Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background

    Sociodemographic factors, attitude towards treatment and acculturation may be important factors influencing the decision of immigrants to seek and maintain psychiatric treatment. A better understanding of thes...

    Eva J. Brandl, Nora Dietrich, Nicoleta Mell, Johanna G. Winkler in BMC Psychiatry (2020)

  4. No Access

    Article

    Are Trained Medical Interpreters Worth the Cost? A Review of the Current Literature on Cost and Cost-Effectiveness

    The treatment of migrants with limited language proficiency poses major challenges to health care professionals. The use of professional interpreters in medical settings is still limited, which is, among other...

    Eva J. Brandl, Stefanie Schreiter in Journal of Immigrant and Minority Health (2020)

  5. No Access

    Article

    Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies

    Genetic variation underlies both the response to antidepressant treatment and the occurrence of side effects. Over the past two decades, a number of pharmacogenetic variants, among these the SCL6A4, BDNF, FKBP5,

    Tristram A. Lett, Henrik Walter, Eva J. Brandl in CNS Drugs (2016)

  6. No Access

    Article

    Genetic variation in CYP3A43 is associated with response to antipsychotic medication

    Genetic variation in cytochrome enzymes is known to affect drug metabolism and influence treatment response. Recently, the rs472660 variant in CYP3A43 has been associated with olanzapine response and clearance. I...

    Eva J. Brandl, Nabilah I. Chowdhury, Arun K. Tiwari in Journal of Neural Transmission (2015)

  7. Article

    A Hypothesis-Driven Association Study of 28 Nuclear-Encoded Mitochondrial Genes with Antipsychotic-Induced Weight Gain in Schizophrenia

    Mitochondria are the main source of energy for neurons and have a role in many vital neuronal functions. Mitochondrial dysfunction has been described in schizophrenia, and antipsychotics such as clozapine and ...

    Vanessa F Gonçalves, Clement C Zai, Arun K Tiwari, Eva J Brandl in Neuropsychopharmacology (2014)